|
Hemofarm a.d. (full legal name: ''Hemofarm a.d.'' Farmaceutsko-hemijska industrija Vršac), a member of STADA Group, is a Serbian pharmaceutical company based in Vršac, Serbia. Founded in 1960, it is one of the largest domestic producer and exporter of medicines in Serbia. Hemofarm currently operates in more than 30 countries on 3 continents and has approximately 2,500 employees. The core activity represents the manufacture of Rx and OTC medicines and products. Portfolio includes over 140 INNs, with about 280 forms and dosage forms. ==History== Hemofarm was founded on June 1, 1960 in Vršac. In 2003 it opened the first factory for the production of medicine in the Republika Srpska. As of 2003 Hemofarm consisted of 21 subsidiaries, 12 of which were located in Serbia and Montenegro. In 2004, the company acquired four other Serbian concerns, increasing its market share from 15% to 45% in the process.〔(''Doing Business with Serbia'' ) By Marat Terterov, Consultant Editor, Marat Terterov, Inc NetLibrary; Published by GMB Publishing Ltd, 2006; ISBN 1-905050-68-2, ISBN 978-1-905050-68-0.〕 As of 2011, the company has a market share in terms of production and import of 30.7%. Hemofarm was bought by the German STADA Arzneimittel pharmaceutical group for 480 million euros in 2006. Since August 9, 2009 Hemofarm has been a member of the German STADA Group. In August 2015, Hemofarm took over Serbian pharmaceutical company ''Ivančić i sinovi''. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Hemofarm a.d.」の詳細全文を読む スポンサード リンク
|